Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases. [electronic resource]
- Current medicinal chemistry Feb 2018
- 525-539 p. digital
Publication Type: Journal Article; Review
1875-533X
10.2174/0929867324666170518094404 doi
Central Nervous System Agents--chemistry Chelating Agents--chemistry Copper--chemistry Drug Repositioning Humans Neurodegenerative Diseases--drug therapy